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Abstract: We have assessed the prevalence of Escherichia coli O157 in diarrhoeal patients 
and surface waters from some selected sources in Zaria (Nigeria), evaluating the antibiotic 
susceptibility and plasmid profiles of 184 E. coli isolates, obtained from 228 water samples 
and 112 diarrhoeal stool specimens (collected from children aged <15 years), using standard 
methods. The detection rate of E. coli O157 in surface waters was 2.2% and its prevalence 
in children with diarrhoea was 5.4%. The most active antibiotics were gentamicin, 
chloramphenicol and fluoroquinolones. Seventy-nine (42.9%) of 184 E. coli isolates were 
resistant to four or more antibiotics. Multidrug resistance (MDR) was higher amongst 
aquatic isolates than the clinical isolates. Out of 35 MDR isolates (20 of which were O157 
strains), 22 (62.9%) harboured plasmids all of which were no less than 2.1 kb in size. 
Amongst the 20 E. coli O157 strains, only seven (35.0%) contained multiple plasmids. An 
aquatic O157 isolate containing two plasmids was resistant to seven drugs, including 
ampicillin, cefuroxime, ciprofloxacin, cotrimoxazole, nalidixic acid, nitrofurantoin and 
OPEN ACCESSInt. J. Environ. Res. Public Health 2010, 7          
 
 
3832
tetracycline. Loss of plasmid correlated with loss of resistance to antibiotics in cured 
(mutant) strains selected in tetracycline (50 μg/mL)-nutrient agar plates. Our  findings 
revealed that plasmids were prevalent in both the aquatic and clinical isolates, and suggest 
that the observed MDR is plasmid-mediated. The occurrence of plasmid-mediated multidrug 
resistant E. coli O157 in surface waters used as sources for drinking, recreation and fresh 
produce irrigation heightens public health concern. 
Keywords:  plasmid-mediated; multidrug resistance; surface water; E. coli O157;   
public health impact 
 
1. Introduction  
Antimicrobial resistance in Enterobacteriaceae poses a critical public health threat, especially in the 
developing countries [1,2]. Much of the problem has been shown to be due to the presence of 
transferable plasmids encoding multidrug resistance and their dissemination among different 
enterobacterial species [3–6].  
Escherichia coli O157 is an important food-borne and water-borne pathogen with a worldwide 
distribution [7]. The first reported outbreak of E. coli O157 infection in the developing world occurred 
in 1992 in Southern Africa [8]. Outbreaks have also occurred in Central African Republic in 1996 and 
Cameroon, in 1997 [9]. Such outbreaks have been linked to contaminated bovine food products, 
contaminated drinking water and flood irrigation with water contaminated by animal faeces or surface 
runoff [8,10], and cattle faeces have been implicated as the major source of contamination [11].  
Although not in outbreak proportions, E. coli O157:H7 illnesses have also been reported in 
Southern Nigeria [12–14]. The absence of reports on the prevalence of E. coli O157 and its associated 
infections in Northern Nigeria (where cattle is widely reared and surface waters serve as important 
sources of water for drinking, herd watering and fresh produce irrigation) and a heightened concern 
over the spread of antimicrobial resistant pathogens made this research imperative. We isolated E. coli 
from surface waters and patients (children aged <15 years) with diarrhoea in parts of Zaria, Nigeria, 
determined the prevalence of E. coli O157 strains, evaluated the antimicrobial susceptibility of all 
aquatic and clinical E. coli isolates, and screened multidrug resistant strains for plasmids.  
2. Experimental Section  
2.1. Isolation and Identification of E. coli and E. coli O157 Strains 
 
The study area, as well as the collection of samples, has been described fully in our previous   
reports [15,16]. The stool samples were collected from diarrhoeal patients (children aged <15 years) 
from two hospitals, the Ahmadu Bello University (ABU) Sick Bay and Jama’a Clinic, Samaru, Zaria. 
E. coli was isolated from water samples using the Tryptic Soy Broth (TSB) enrichment and high 
temperature incubation method described by LeJeune et al. [17]. Briefly, 20 mL of each water   
sample was combined with equal volume of double strength TSB (Difco; Detroit, MI, USA) in a  Int. J. Environ. Res. Public Health 2010, 7          
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cotton-plugged 150 mL conical flask and incubated at 44.5 °C for 24 h. The resulting suspension  
(50 μL) was then spread plated into EMB agar. At least three discrete colonies from each water sample 
were randomly selected from each EMB agar plate and screened for on Sorbitol MacConkey (SMAC) 
agar plates (Oxoid; Basingstoke, UK). Stool specimens were cultured for E. coli isolation on EMB 
agar and incubated at 44.5 °C as described by Okeke et al. [18] and screened on SMAC. After 
incubation at 37 °C for 24 h all non-sorbitol (colourless) colonies were subjected to confirmation as  
E. coli isolates by Gram-staining and standard biochemical tests and recorded as presumptive E. coli 
O157. Confirmation of E. coli O157 was done by testing for agglutination with E. coli O157 antisera 
(Oxoid). EHEC strain EDL 933 was used as positive control. 
 
2.2. Antimicrobial Susceptibility Testing 
 
All E. coli isolates were tested for antimicrobial resistance using the method of Bauer et al. [19] on 
standard antibiotic discs (PS003G-VE, Polytes Laboratories, Enugu, Nigeria) using the following 
antibiotics: ampicillin (25 μg), cefuroxime (20 μg), chloramphenicol (10 μg), ciprofloxacin (5 μg), 
cotrimoxazole (50 μg), gentamicin (10 μg), nalidixic acid (30 μg), nitrofurantoin (100 μg), norfloxacin 
(10 μg) and tetracycline (50 μg). E. coli ATCC 25922 was used as control organism, and the results 
were interpreted using the Clinical and Laboratory Standards Institute (CLSI) criteria [20].  
 
2.3. Plasmid Extraction, Screening and Curing 
 
Extraction of plasmid DNA was done using the alkaline lysis method of Birnboim and Doly [21].  
A 0.8% (w/v) agarose gel was used. Crude DNA extract solutions were subjected to electrophoresis 
using a horizontal apparatus—the Minnie submarine agarose gel unit (HE33; Hoefer, San Francisco, 
CA, USA) and a constant voltage (60V) power source (P500B; Sigma, St. Louis, MO, USA) for 2–3 h 
as described Meyers et al. [22]. Gels were observed using a 302 nm UV trans-illuminator (Vilber 
Lourmat) and photographed with a Polaroid camera. The sizes of the plasmids were estimated   
as described elsewhere [22,23]. The sodium dodecyl sulphate (SDS) treatment method of   
Tomoeda et al. [24] was used for plasmid curing. Tetracycline-resistant, plasmid-containing E. coli 
isolates were chosen and subjected to curing and antibiotic susceptibility testing. After the curing 
experiments, the tetracycline-susceptible, lactose-fermenting and indole-positive colonies found to 
have lost their plasmid(s) were considered cured (mutant) E. coli strains, transferred onto nutrient agar 
slants, incubated at 37 °C for 24 h, and subjected to antibiotic susceptibility testing as already 
described, using the same set of antibiotics. 
3. Results and Discussion  
3.1. Prevalence of E. coli O157and Antibiotic Susceptibility of Isolates 
A total of 184 E. coli isolates were obtained from 228 water samples and 112 diarrhoeal stool 
specimens. Twenty-one (11.4%) of these 184 isolates were found to be non-sorbitol-fermenting, out of 
which 20 (95.2%) were confirmed to be E. coli O157 by slide agglutination. Table 1 shows the Int. J. Environ. Res. Public Health 2010, 7          
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prevalence of Escherichia coli O157 in surface waters and among diarrhoeal patients. Only five of  
the 228 water samples were positive for E. coli O157, corresponding to an isolation rate of 2.2 %. Only 
six of the 112 stool specimens gave positive cultures of E. coli O157, and hence a prevalence of 5.4%. 
 
Table 1. Prevalence of Escherichia coli O157 in Surface waters and among Diarrhoeal 
Patients in Zaria, Nigeria. 
Sample Source 
Number (%) of  Number (%) positive 
Collected Samples  for E. coli O157 
Water 
Samaru Stream  58 (25.4)  1 (1.7) 
Kubanni River  96 (42.1)  2 (2.1) 
ABU Dam  74 (32.5)  2 (2.7) 
Total  228 (100.0)  5 (2.2) 
Diarrhoeal Stool 
ABU Sick Bay  35 (31.3)  1 (2.9) 
Jama’a Clinic  77 (68.7)  5 (6.5) 
Total  112 (100.0)  6 (5.4) 
 
Table 2 shows the antimicrobial susceptibility patterns of 184 E. coli, isolated from clinical and 
water samples, using 10 antibiotics. Gentamicin, norfloxacin and chloramphenicol were the most 
active. While all of the clinical isolates were sensitive to both gentamicin and norfloxacin, and only 
6.8% was resistant to chloramphenicol, only 2.1%, 4.9% and 5.4% of the aquatic isolates were, 
resistant to the three antibiotics, respectively. Also, of the 184 isolates, 154 (83.7%) and 123 (66.8%) 
were resistant to ampicillin and tetracycline, respectively, implying that ampicillin and tetracycline 
were the least active. 
Table 3 reveals the multidrug resistance (MDR) patterns of the 184 E. coli isolates. MDR was 
higher amongst aquatic isolates than the clinical isolates. While 58 (60.4 %) of the aquatic strains 
showed resistance to ampicillin, tetracycline and nitrofurantoin, only 22 (25 %) of the clinical isolates 
gave similar results. Overall, higher numbers of resistant isolates were identified among the aquatic 
isolates. The highest levels of MDR observed were in two aquatic isolates: one was resistant to eight 
antibiotics and another to nine of the 10 antibiotics tested, including ampicillin, cefuroxime, 
chloramphenicol, ciprofloxacin, cotrimoxazole, gentamicin, nalidixic acid, norfloxacin and 
tetracycline. 
Table 4 shows that amongst the 20 E. coli O157 isolates (14 aquatic and six clinical strains), the 
most active antibiotics were the fluoroquinolones and chloramphenicol. While none (0.0 %) was 
resistant to norfloxacin, three (15 %) showed intermediate susceptibility and 17 (85 %) were sensitive. 
For ciprofloxacin, while 18 (90%) were sensitive, only 2 (10%) were sensitive. Seventeen (85 %) were 
sensitive to chloramphenicol. Further, 16 (80 %) of the E. coli O157 isolates were sensitive to each of 
cotrimoxazole and gentamicin. All (100 %) of the six clinical O157 isolates were sensitive to 
ciprofloxacin and chloramphenicol, while five (83.3 %) and three (50 %) were resistant to tetracycline 
and ampicillin respectively. Amongst the 14 aquatic isolates, while 10 (71.4%) were resistant   
to ampicillin and tetracycline, nine (64.3%) were resistant to nitrofurantoin and 13 (93%)   
to chloramphenicol. Int. J. Environ. Res. Public Health 2010, 7         
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Table 2. Antimicrobial Susceptibility Pattern of E .coli Isolated from Clinical and Water Samples. 
S/N 
Antimicrobial 
Agent 
Symbol 
Disc 
Content 
(µg) 
   Susceptibility        
Clinical Isolates (n = 88)   Aquatic Isolates (n = 96)   Resistant Isolates 
Combined (n= 184) 
No. (%) 
R 
No. (%) 
I 
No. (%) 
S 
No. (%) 
  R 
No. (%) 
I 
No. (%) 
S 
No. (%) 
 
  
1  Ampicillin  Amp  25  71 (80.7)  14 (15.9)  3 (3.4)  83 (86.5)  5 (5.2)  8 (8.3)  154 (83.7) 
2  Cefuroxime  Cef  20  28 (31.8)  9 (10.2)  51 (58.0)   71 (74.0)  11 (11.4)  14 (14.6)  99 (53.8) 
3  Chloramphenicol  Chl  10  6 (6.8)  0 (0.0)  82 (93.2)   4 (4.2)  1 (1.0)  91 (94.8)  10 (5.4) 
4  Ciprofloxacin  Cip  5  17 (19.3)  3 (3.4)  68 (77.3)   11 (11.5)  2 (2.1)  83 (86.4)  28 (15.2) 
5  Cotrimoxazole  Cot  50  9 (10.2)  2 (2.3)  77 87.5   14 (14.6)  2 (2.1)  80 (83.3)  23 (12.5) 
6  Gentamicin  Gen  10  0.(0.0)  0 (0.0)  88 (100)   2 (2.1)  7 (7.3)  87 (90.6)  2 (1.1) 
7  Nalidixic Acid  Nal  30  48 (54.6)  9 (10.2)  31 (35.2)   68 (70.8)  9 (9.4)  19 (19.8)  116 (63.0) 
8  Nitrofurantoin  Nit  100  45 (51.2)  6 (6.8)  37 (42.1)   76 (79.1)  4 (4.2)  16 (16.7)  121 (65.8) 
9  Norfloxacin  Nor  10  0 (0.0)  6 (6.8)  82 (93.2)   9 (9.4)  5 (5.2)  82 (85.4)  9 (4.9) 
10  Tetracycline  Tet  50  54 (61.4)  5 (5.6)  29 (33.0)     69 (71.9)  7 (7.3)  20 (20.8)  123 (66.8) 
Legend: R, resistant; I, intermediate; S, sensitive. 
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Table 3. Resistance Patterns of Aquatic and Clinical in E. coli Isolates. 
Number of 
Antibiotics 
Combination of Antibiotics* 
  
Aquatic Isolates 
(n = 96) 
Clinical Isolates 
(n = 88) 
Total  E. coli O157 
(n = 184) Isolates (n = 20) 
2 Amp,  Cef    59(61.50)  8(9.1)  67(36.4) 12(60.0) 
2 Amp,  Cot  13(13.5)  4(4.5)  17(9.2)  2(10.0) 
2 Amp,  Tet  63(65.6)  39(44.3)  102(55.4) 13(65.0) 
2 Cot,  Tet  10(10.4)  5(5.7)  15(8.2)  2(65.0) 
3 Amp,Tet,  Chl  5(5.2)  2(2.3)  7(3.8)  1(0.0) 
3  Amp, Cot, Nit  9(9.4)  3(3.4)  12(6.5)  1(5.0) 
3  Amp, Tet, Cot  9(9.4)  4(4.5)  13(7.1)  1(5.0) 
3  Amp, Tet, Nit  58(60.4)  22(25.0)  80(43.5) 9(45.0) 
4  Amp, Tet, Nal, Nit   50(52.1)  21(23.4)  71(38.6) 9(45.0) 
5  Amp, Tet, Cip, Nal, Nit  8(8.3)  5(5.7)  13(7.1)  1(5.0) 
6  Amp, Tet, Cip, Cot, Nal, Nit  6(6.3)  3(3.4)  9(4.9)  1(5.0) 
7  Amp, Tet, Cip, Cef, Cot, Nal, Nit  2(2.1)  1(1.1)  3(1.6)  1(5.0) 
8  Amp, Tet, Cip,Cef, Cot,Chl, Nal, Nit  1(1.0)  0(0.0)  1(0.5)  0(0.0) 
9  Amp, Tet, Cip,Cef, Cot,Chl, Gen, Nal, Nor  1(1.0)  0(0.0)  1(0.5)  0(0.0) 
Symbols: Amp, ampicillin; Cef, cefuroxime; Cot, cotrimoxazole; Tet, tetracycline; Chl, chloramphenicol; Nit, nitrofurantoin; Nal, nalidixic acid; Cip, 
ciprofloxacin; Gen, gentamicin; Nor, norfloxacin. Int. J. Environ. Res. Public Health 2010, 7          
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Table 4. Antimicrobial susceptibility pattern of E. coli O157 strains isolated from clinical 
and water samples. 
S/N 
 
Antimicrobial 
Agent 
Symbol 
Disc 
Content 
(µg) 
Susceptibility (n = 20) 
Resistant 
No. (%) 
Intermediate 
No. (%) 
Sensitive 
No. (%) 
1  Ampicillin  Amp  25  13 (65.0)  5 (25.0)  2 (10.0) 
2  Cefuroxime  Cef  20  10 (50.0)  3 (15.0)  7 (35.0) 
3  Chloramphenicol  Chl  10  1 (5.0)  2 (10.0)  17 (85.0) 
4  Ciprofloxacin  Cip  5  2 (10.0)  0 (0.0)  18 (90.0) 
5  Cotrimoxazole Cot 50 3  (15.0)  1  (5.0)  16  (80.0) 
6 Gentamicin  Gen 10 2  (10.0)  2  (10.0)  16  (80.0) 
7  Nalidixic Acid  Nal  30  11 (55.0)  2 (10.0)  7 (35.0) 
8  Nitrofurantoin  Nit  100  9 (45.0)  3 (15.0)  8 (40.0) 
9  Norfloxacin  Nor  10  0 (0.0)  3 (15.0)  17 (85.0) 
10  Tetracycline  Tet  50  15 (75.0)  2 (10.0)  3 (15.0) 
 
3.2. Plasmid Studies 
 
Thirty-five multidrug-resistant E. coli isolates were screened for plasmids. This consisted of 23 
aquatic and 12 clinical isolates, grouped further into 20 E. coli O157 strains and 15 non-O157 strains. 
Table 5 shows that 22 (62.9%), of the 35, haboured plasmids (>2.1 Kb). The table further reveals that 
out of the 22 plasmid-containing isolates, only seven (JC17, JC15, LR 11, BS12, AS04, FD08 and 
FD07), marked with asterisks (*) are E. coli O157 strains. All (100%) of the 15 non-O157 isolates 
contained plasmids. The resistance level observed in this 22 ranged from two-drug resistance   
(Isolate JC17) to nine-drug resistance (Isolate AS03).  
All (100%) of the 22 plasmid-containing isolates were resistant to tetracycline, while only 10 
(45.5%) were resistant to ciprofloxacin. In all, eight isolates contained two or more plasmids, giving a 
prevalence of 22.9%. Each of the isolates bearing multiple plasmids was resistant to at least four 
antibiotics. Interestingly, Isolate AS03 which showed resistance to nine different antibiotics contained 
only one plasmid. 
Amongst the 20 E. coli O157 isolates, the DNA fingerprints revealed that only seven (35%) 
contained plasmids, out of which three (15%) contained more than one plasmid. One of the aquatic 
isolates (FD07) containing two plasmids was resistant to seven drugs including ampicillin, cefuroxime, 
ciprofloxacin, cotrimoxazole, nalidixic acid, nitrofurantoin and tetracycline. No clinical E. coli O157 
isolate contained multiple plasmids.  
Plasmid curing experiments were carried out to determine if the drug resistance observed in this 
study was plasmid-mediated. No plasmid bands were observed after the electrophoretic separation of 
crude DNA extracts from seven tetracycline-susceptible mutants. Loss of plasmids correlated with loss 
of resistance to antibiotics in cured strains selected on tetracycline (50 µg/mL)-nutrient agar plates. 
Loss of resistance to multiple antibiotics was also observed. Six (86%) of the tetracycline-susceptible 
mutant showed sensitivity to tetracycline and ampicillin.  
 Int. J. Environ. Res. Public Health 2010, 7          
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Table 5. Plasmid Profile and Multidrug Resistance Patterns of Plasmid-Containing E. coli Isolates. 
E. coli isolates  Number of plasmids 
Antibiotics to which Isolates were Resistant 
Number Combinations** 
JC17* 1  2  Amp,  Tet 
JC15*  1  3  Amp, Tet, Cot 
LR11*  2  4  Amp, Tet, Nit, Nal 
JC11  1  4  Amp, Tet, Nit, Nal 
BS12*  1  4  Amp, Tet, Nit, Cef 
JC28  1  4  Amp, Tet, Cip, Cot 
AS04*  1  5  Amp, Tet, Nit, Nal, Cef, 
FD08*  2  5  Amp, Tet, Nit, Nal, Cef 
AS06  1  5  Amp, Tet, Nit, Nal, Cef 
SB06  2  5  Amp, Tet, Nit, Nal, Cip 
SB13  1  5  Amp, Tet, Nit, Nal, Cip 
KR10  1  5  Amp, Tet, Nit, Nal, Cot 
HR09  1  5  Cef, Tet, Nit, Nal, Cot 
SB04  2  6  Amp, Tet, Nit, Nal, Cip, Cot 
IR10  1  6  Amp, Tet, Nit, Nal, Cef, Cot 
JC13  1  6  Amp, Tet, Cef, Cip, Cot, Chl 
FD07*  2  7  Amp, Tet, Nit, Nal, Cef, Cip, Cot 
SB09  2  7  Amp, Tet, Nit, Nal, Cef, Cip, Cot 
JR10  3  7  Amp, Tet, Nit, Nal, Cef, Cip, Cot 
BS06  1  7  Amp, Tet, Nit, Nal, Cef, Cot, Chl 
KR08  2  8  Amp, Tet, Nit, Nal, Cef, Cip, Cot, Chl 
AS03  1  9  Amp, Tet, Nit, Nal, Cip, Cot, Chl, Gen, Nor 
Legend: * E. coli O157 strains; **Amp, ampicllin; Cef, cefuroxime; Cot, cotrimoxazole; Tet, tetracycline; 
Chl, chloramphenicol; Nit, nitrofurantoin; Nal, nalidixic acid; Cip, ciprofloxacin; Gen, gentamicin;   
Nor, norfloxacin. 
 
3.3. Discussion 
 
The detection of E. coli O157 at relatively high frequencies in these waters (stream, 1.7%;   
dam, 2.7%; river, 2.1%) and its occurrence heighten public health concern about these surface waters 
that are sources of raw water treated for drinking, recreation, irrigation and herd watering [25]. 
Kubanni River, used by local farmers for the irrigation of commercial crops (tomatoes, lettuce, 
cabbage, onions, spinach, sugarcane etc), has been reported as unfit for fresh produce irrigation [26]. 
The 5.4% prevalence of E. coli O157 in children with diarrhoea suggests that the epidemiological 
situation in Nigeria had remained the same since 1994 [14]. 
Comparison of antibiotic susceptibility in clinical and water isolates showed that higher levels of 
resistance existed in the aquatic isolates. This agrees with the findings of Idika [25], who studied 
Vibrio cholerae isolates during an outbreak of cholera in Lagos in 1997 and reported that the isolates 
from water were resistant to tetracycline and gentamicin whereas clinical isolates were susceptible. 
Our findings which are not enough to suggest any epidemiological link between the aquatic and 
clinical strains concur with that of Okoh and Igbinosa [26]. They studied antibiotic susceptibility Int. J. Environ. Res. Public Health 2010, 7          
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patterns of the Vibrio isolates as well as the distribution of antibiotic resistance genes in the isolates 
and found that previous use of antibiotics in earlier outbreaks may be, in part, responsible for the 
extensive increase in antibiotics resistance. It is unknown whether the isolates responsible for earlier 
and recent epidemics are of the same clonal origin. The association between the development of 
resistance to ampicillin and tetracycline with large-scale use of antibiotics for treatment and 
prophylaxis of diarrhoea is well recognized Idika [25]. Ash et al. [27] also reported high levels of 
resistance in gram-negative bacteria in rivers in the United States.  
All (100%) of the 22 plasmid-containing isolates were resistant to tetracycline. This is worrisome 
considering that tetracycline is a first line drug in Nigeria, and as in most developing countries, people 
with gastrointestinal infections readily purchase it across the counter for self-medication. 
From the results, it appears that plasmids are ubiquitous in bacterial population in the waters. 
Different plasmids (2–3) often coexisted in the same host cell. This agrees with the finding of   
Fujita et al. [28] who isolated 45 antibiotic resistant bacteria from wastewater samples and detected 31 
plasmids in 14 of 45 antibiotic resistant strains with 10 carrying multiple (2–4) plasmids. The 
demonstration of high-molecular-weight plasmids in the isolates, and the finding that the expressed 
multi-drug resistance (MDR) was plasmid-mediated is significant. McPherson and Gealt [3] showed 
that several enteric bacterial strains isolated from wastewater samples and possessing both antibiotic 
resistance and high molecular-weight plasmids could transfer their resistance to other recipient 
bacteria. The transmissibility of resistance (R)-genes and plasmids poses public health risk, 
considering the vast potential of hosts presented by microbial populations in the gut and water 
environment. This risk could be heightened if R-genes are disseminated across geographic borders by 
travellers or by a river continuum, like Kubanni that traverses different communities within the   
study area.  
Mutant cells obtained by SDS treatment of tetracycline-resistant isolates were susceptible to 
tetracycline suggesting that a part or all of their resistance genes must have been deleted by SDS 
action. Loss of plasmids correlated with loss of resistance to ampicillin, chloramphenicol, 
ciprofloxacin, norfloxacin and tetracycline in 6 (86%) of the mutants. It therefore appears that the 
observed multi-drug resistance to these antibiotics was plasmid-mediated. This agrees with   
previous findings.  
Ash et al. [27] had in a study of the antibiotic resistance of gram-negative bacteria in rivers in the 
United States demonstrated that resistance to ampicillin and other drugs (including ciprofloxacin, 
tetracycline, chloramphenicol, kanamycin and streptomycin) was plasmid-mediated. Interestingly, two 
mutants now resistant to cotrimoxazole originated from wild-type E. coli O157 isolates that were 
sensitive to the same drug. This could be attributed to possible mutation affecting chromosomal genes 
in the course of the curing experiment [29].  
4. Conclusions  
Pathogenic Escherichia coli isolated from these surface water and clinical sources were found to be 
resistant to tetracycline, cotrimoxazole, ampicillin and other commonly used antibiotics. Higher levels 
of resistance were observed in aquatic isolates. Multidrug resistance and plasmid were observed in 
both aquatic and clinical isolates. Loss of plasmids due to treatment with sodium dodecyl-sulphate Int. J. Environ. Res. Public Health 2010, 7          
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correlated with loss of resistance to antibiotics, suggesting that the observed multidrug resistance was 
plasmid-mediated. The occurrence of plasmid-mediated multidrug resistance in bacteria in these 
surface waters heightens the public health concern. The study showed a need for a continuous 
pollution monitoring programme of the surface waters in Nigeria.  
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